My Cart

0 Item(s): $0.00

You have no items in your shopping cart.

Abacavir Lamivudine And Dolutegravir

Abacavir Lamivudine And Dolutegravir

Why is this medication prescribed?

The combination of abacavir, dolutegravir, and lamivudine is used alone or along with other medications to treat HIV infection. Abacavir and lamivudine are in a class of medications called nucleoside analogue reverse transcriptase inhibitors (NRTIs) and dolutegravir is in a class of medications called integrase strand transfer inhibitors (INSTIs). They work by decreasing the amount of HIV in your blood and increasing the number of immune cells that help fight infections in your body. Although abacavir, dolutegravir, and lamivudine will not cure HIV, these medications may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of getting or transmitting the HIV virus to other people.

Missed doses

If the patient misses a dose of Triumeq, the patient should take Triumeq as soon as possible, providing the next dose is not due within 4 hours. If the next dose is due within 4 hours, the patient should not take the missed dose and simply resume the usual dosing schedule.

Uses of Dolutegravir & Abacavir & Lamivudine

Dolutegravir/abacavir/lamivudine is a prescription medication used to treat HIV infection.

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Dolutegravir & Abacavir & Lamivudine Brand Names

Dolutegravir & Abacavir & Lamivudine may be found in some form under the following brand names:

  • Triumeq


Contraindicated in:

  • Hypersensitivity to any component (especially abacavir, rechallenge may be fatal);
  • Resistance to any component;
  • Presence of HLA-B*5701 allele;
  • Concurrent use of dofetilide;
  • Concurrent administration of lamivudine or abacavir alone or in other combination antiretroviral dose forms;
  • Lactation: Breast feeding not recommended for HIV-infected patients;
  • Moderate to severe liver impairment;
  • CCr <50 mL/min.

Dolutegravir & Abacavir & Lamivudine and Lactation

Do not breastfeed if you have HIV-1 because of the risk of passing HIV-1 to your baby.

Know More About This Medicine and Buy Now :